AstraZeneca sees stock market value slump by more than £20bn after drug setback
The FTSE 100 firm found the Wainua drug failed to meet a goal to reduce deaths related to heart disease. AstraZeneca has seen more than £20 billion wiped off its stock market value after being hit by…
Read the full articleYou might also wanna read
Donald Trump warns Iran against pursuing any assassination attempt
perspectivemedia.com·1h ago
England fans say Mexico win builds momentum to beat Norway and lift World Cup
perspectivemedia.com·3h ago
Burnham urged to reverse national insurance rise costing firms £1,000 per worker
perspectivemedia.com·6h ago
Man in custody after arrest on suspicion of murdering Ann Widdecombe
perspectivemedia.com·6h ago
MPs back benefit boost for 66-year-olds as state pension age increases
perspectivemedia.com·6h ago
US demands Iran publicly guarantees Strait of Hormuz is open and safe for ships
perspectivemedia.com·7h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.